Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

NCT05640245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

DRUG: Sonelokimab
DRUG: Placebo
DRUG: Adalimumab

Sponsor

MoonLake Immunotherapeutics AG